Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 694

Similar articles for PubMed (Select 19695683)

1.

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.

Muenst S, Hoeller S, Dirnhofer S, Tzankov A.

Hum Pathol. 2009 Dec;40(12):1715-22. doi: 10.1016/j.humpath.2009.03.025. Epub 2009 Aug 19.

PMID:
19695683
2.

Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.

Richendollar BG, Pohlman B, Elson P, Hsi ED.

Hum Pathol. 2011 Apr;42(4):552-7. doi: 10.1016/j.humpath.2010.08.015. Epub 2011 Jan 15.

PMID:
21237493
3.

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.

Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S.

Haematologica. 2008 Feb;93(2):193-200. doi: 10.3324/haematol.11702. Epub 2008 Jan 26.

4.

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E.

J Clin Oncol. 2009 Mar 20;27(9):1470-6. doi: 10.1200/JCO.2008.18.0513. Epub 2009 Feb 17.

6.

PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.

Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Domínguez-Franjo P, Piris MA.

Am J Surg Pathol. 2008 Aug;32(8):1252-7. doi: 10.1097/PAS.0b013e318165b0d6.

PMID:
18594468
7.

Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.

Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS, Kim CW.

Ann Oncol. 2009 Oct;20(10):1688-96. doi: 10.1093/annonc/mdp056. Epub 2009 Jun 19.

8.

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA.

Mod Pathol. 2009 Aug;22(8):1006-15. doi: 10.1038/modpathol.2009.54. Epub 2009 May 22.

9.

Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.

Churchill HR, Roncador G, Warnke RA, Natkunam Y.

Hum Pathol. 2010 Dec;41(12):1726-34. doi: 10.1016/j.humpath.2010.05.010. Epub 2010 Sep 9.

PMID:
20825974
10.

Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma.

Hsu MC, Hsiao JR, Chang KC, Wu YH, Su IJ, Jin YT, Chang Y.

Mod Pathol. 2010 Oct;23(10):1393-403. doi: 10.1038/modpathol.2010.130. Epub 2010 Jul 23.

11.

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.

Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, Christensson B, Sander B, Kimby E.

Clin Cancer Res. 2010 Jan 15;16(2):637-50. doi: 10.1158/1078-0432.CCR-09-2487. Epub 2010 Jan 12.

12.

Peripheral T-cell lymphoma with follicular T-cell markers.

Rodríguez-Pinilla SM, Atienza L, Murillo C, Pérez-Rodríguez A, Montes-Moreno S, Roncador G, Pérez-Seoane C, Domínguez P, Camacho FI, Piris MA.

Am J Surg Pathol. 2008 Dec;32(12):1787-99. doi: 10.1097/PAS.0b013e31817f123e.

PMID:
18779728
13.

Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.

Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y, Sozaki M, Tanaka M, Onishi H, Morisaki T, Katano M.

Cancer Immunol Immunother. 2010 May;59(5):653-61. doi: 10.1007/s00262-009-0781-9. Epub 2009 Nov 12.

PMID:
19908042
14.

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.

Lee NR, Song EK, Jang KY, Choi HN, Moon WS, Kwon K, Lee JH, Yim CY, Kwak JY.

Leuk Lymphoma. 2008 Feb;49(2):247-56. doi: 10.1080/10428190701824536.

PMID:
18231910
15.

Diagnostic and prognostic utility of PD-1 in B cell lymphomas.

Muenst S, Hoeller S, Willi N, Dirnhofera S, Tzankov A.

Dis Markers. 2010;29(1):47-53. doi: 10.3233/DMA-2010-0725.

16.

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.

Roncador G, García Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T.

Haematologica. 2007 Aug;92(8):1059-66. Epub 2007 Jul 20.

17.

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.

Rodríguez Pinilla SM, Roncador G, Rodríguez-Peralto JL, Mollejo M, García JF, Montes-Moreno S, Camacho FI, Ortiz P, Limeres-González MA, Torres A, Campo E, Navarro-Conde P, Piris MA.

Am J Surg Pathol. 2009 Jan;33(1):81-90. doi: 10.1097/PAS.0b013e31818e52fe.

PMID:
18987541
18.

Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.

Alvaro-Naranjo T, Lejeune M, Salvadó-Usach MT, Bosch-Príncep R, Reverter-Branchat G, Jaén-Martínez J, Pons-Ferré LE.

Leuk Lymphoma. 2005 Nov;46(11):1581-91.

PMID:
16236613
19.

Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.

Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA.

Mod Pathol. 2009 Jun;22(6):753-61. doi: 10.1038/modpathol.2009.12. Epub 2009 Mar 27.

20.

Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.

Karim R, Jordanova ES, Piersma SJ, Kenter GG, Chen L, Boer JM, Melief CJ, van der Burg SH.

Clin Cancer Res. 2009 Oct 15;15(20):6341-7. doi: 10.1158/1078-0432.CCR-09-1652. Epub 2009 Oct 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk